共有 50 笔近期内部人交易记录记录，涉及 Apogee Therapeutics, Inc. (APGE), 包括 12 笔买入 和 38 笔卖出. 内部人买入总额为 $36.44M 内部人卖出总额为 $141.26M.
近期活跃的重要内部人包括 Henderson Jane, Dambkowski Carl, Henderson Michael Thomas. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — APGE
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-01 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
1,100 |
$85.46 |
$94.01K |
177,371 |
| 2026-04-01 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
4,125 |
$22.86 |
$94.3K |
127,165 |
| 2026-03-25 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
2,000 |
$85.00 |
$170K |
179,371 |
| 2026-03-11 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
3,418 |
$75.86 |
$259.29K |
1,152,987 |
| 2026-03-04 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
4,125 |
$22.86 |
$94.3K |
131,290 |
| 2026-03-02 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
406 |
$71.66 |
$29.09K |
181,371 |
| 2026-02-11 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
955 |
$64.99 |
$62.07K |
1,172,987 |
| 2026-02-04 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
4,125 |
$22.86 |
$94.3K |
135,415 |
| 2026-02-02 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
100 |
$66.89 |
$6.69K |
183,371 |
| 2026-01-22 |
Fairmount Funds Management Llc |
Director |
知情卖出 |
1,750,000 |
$76.30 |
$133.53M |
298,647 |
| 2026-01-14 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
470 |
$83.79 |
$39.38K |
1,192,987 |
| 2026-01-07 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
14,025 |
$22.86 |
$320.61K |
139,540 |
| 2026-01-06 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
2,000 |
$80.00 |
$160K |
185,371 |
| 2026-01-02 |
Henderson Jane |
Chief Financial Officer |
限制性股票授予 (RSU) |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2026-01-02 |
Henderson Michael Thomas |
Chief Executive Officer |
限制性股票授予 (RSU) |
253,016 |
$75.78 |
$19.17M |
253,016 |
| 2026-01-02 |
Dambkowski Carl |
Chief Medical Officer |
限制性股票授予 (RSU) |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2025-12-19 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
1,500 |
$80.00 |
$120K |
193,371 |
| 2025-12-10 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
560 |
$76.58 |
$42.88K |
1,212,987 |
| 2025-12-04 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
1,500 |
$75.00 |
$112.5K |
194,871 |
| 2025-12-04 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
40,000 |
$75.01 |
$3M |
1,232,987 |
| 2025-12-04 |
Dambkowski Carl |
Chief Medical Officer |
知情卖出 |
10,900 |
$75.00 |
$817.5K |
271,108 |
| 2025-11-25 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
1,500 |
$70.00 |
$105K |
196,371 |
| 2025-11-14 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
2,000 |
$65.00 |
$130K |
197,871 |
| 2025-11-13 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
100 |
$64.52 |
$6.45K |
1,272,987 |
| 2025-11-11 |
Henderson Jane |
Chief Financial Officer |
知情卖出 |
1,000 |
$60.00 |
$60K |
199,871 |
| 2025-11-05 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
8,060 |
$22.86 |
$184.25K |
153,565 |
| 2025-10-10 |
Shah Nimish P |
Director |
知情买入 |
365,853 |
- |
- |
365,853 |
| 2025-10-01 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
2,385 |
$22.86 |
$54.52K |
161,625 |
| 2025-09-03 |
Dambkowski Carl |
Chief Medical Officer |
知情卖出 |
190 |
$38.55 |
$7.32K |
233,548 |
| 2025-08-06 |
Dambkowski Carl |
Chief Medical Officer |
知情卖出 |
2,725 |
$37.78 |
$102.95K |
236,273 |
| 2025-07-02 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
7,365 |
$22.86 |
$168.36K |
164,010 |
| 2025-06-17 |
Jones William A Jr |
Director |
限制性股票授予 (RSU) |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Shah Nimish P |
Director |
限制性股票授予 (RSU) |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Mckenna Mark C. |
Director |
限制性股票授予 (RSU) |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fairmount Funds Management Llc |
Director |
限制性股票授予 (RSU) |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fox Jennifer A. |
Director |
限制性股票授予 (RSU) |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Gottesdiener Andrew |
Director |
限制性股票授予 (RSU) |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Bollinger Lisa |
Director |
限制性股票授予 (RSU) |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-04 |
Dambkowski Carl |
Chief Medical Officer |
知情卖出 |
2,725 |
$36.96 |
$100.72K |
241,723 |
| 2025-05-07 |
Dambkowski Carl |
Chief Medical Officer |
知情卖出 |
2,725 |
$35.75 |
$97.42K |
244,448 |
| 2025-04-02 |
Dambkowski Carl |
Chief Medical Officer |
知情卖出 |
889 |
$37.59 |
$33.42K |
247,173 |
| 2025-03-05 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
2,674 |
$30.62 |
$81.88K |
1,292,987 |
| 2025-03-05 |
Dambkowski Carl |
Chief Medical Officer |
知情卖出 |
1,590 |
$30.48 |
$48.46K |
251,033 |
| 2025-02-05 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
15,000 |
$40.58 |
$608.7K |
1,302,987 |
| 2025-02-05 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
795 |
$22.86 |
$18.17K |
171,375 |
| 2025-01-31 |
Henderson Michael Thomas |
Chief Executive Officer |
期权行权（卖出） |
8,500 |
$22.86 |
$194.31K |
390,012 |
| 2025-01-08 |
Henderson Michael Thomas |
Chief Executive Officer |
知情卖出 |
2,868 |
$49.38 |
$141.62K |
1,309,487 |
| 2025-01-02 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
1,360 |
$22.86 |
$31.09K |
172,170 |
| 2024-12-12 |
Mckenna Mark C. |
Director |
知情买入 |
7,500 |
$49.02 |
$367.65K |
7,500 |
| 2024-12-11 |
Dambkowski Carl |
Chief Medical Officer |
期权行权（卖出） |
1,815 |
$22.86 |
$41.49K |
173,530 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
